Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral Hemorrhage
NCT06760078Phase 4Not yet recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Dec 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in intracerebral hemorrhage (ICH), sponsored by Xuanwu Hospital. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT06760078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06760078.